Comparison of effects of losartan versus enalapril on fibrinolysis and coagulation in patients with acute myocardial infarction.
Soejima
H
H
Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Kumamoto, Japan.
Ogawa
H
H
Suefuji
H
H
Kaikita
K
K
Takazoe
K
K
Miyamoto
S
S
Kajiwara
I
I
Shimomura
H
H
Sakamoto
T
T
Yoshimura
M
M
Nakamura
S
S
D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D001779:Blood Coagulation Factors / Q000378:metabolism*; D004311:Double-Blind Method; D004656:Enalapril / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D019808:Losartan / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D015849:Plasminogen Inactivators / Q000097:blood; D015912:Thrombolytic Therapy; D013925:Thromboplastin / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000097:blood
D001779:Blood Coagulation Factors; D015849:Plasminogen Inactivators; D004656:Enalapril; D013925:Thromboplastin; D010959:Tissue Plasminogen Activator; D019808:Losartan